Calendar Day One Biopharmaceuticals, Inc.

Equities

DAWN

US23954D1090

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
15.19 USD -8.71% Intraday chart for Day One Biopharmaceuticals, Inc. +3.97% +4.04%

Chart calendar Day One Biopharmaceuticals, Inc.

cda500c68a0e6c6f5346775.dtB5vQO5Txodh1GZtup0TkbEonu-NgYqsgl9NHAwMt0.FaYsjHfJI3FM9TXL79IQKHH9kw2KclF8wDsyexJ6YKsHli3IaIkmWFvpZQ~462e4a1834e07a44802f205351a6cade

Upcoming events on Day One Biopharmaceuticals, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-05-23 12:00 pm Annual General Meeting
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-03 Q3 2024 Earnings Release (Projected)
2025-03-09 Q4 2024 Earnings Release (Projected)

Past events on Day One Biopharmaceuticals, Inc.

2024-04-24 08:30 am OJEMDA™ FDA Approval Call
2024-03-05 09:50 am TD Cowen Health Care Conference
2024-02-26 04:30 pm Q4 2023 Earnings Release
2024-01-08 01:30 pm JPMorgan Healthcare Conference
2023-11-28 11:30 am Piper Sandler Healthcare Conference
2023-11-17 01:25 pm Society for Neuro Oncology Meeting - Abstract Number : CTNI-37
2023-11-17 01:15 pm Society for Neuro Oncology Meeting - Abstract Number : CTNI-24
2023-11-06 04:30 pm Q3 2023 Earnings Release
2023-09-10 Morgan Stanley Global Healthcare Conference
2023-08-07 Wedbush PacGrow Healthcare Conference
2023-08-07 04:30 pm Q2 2023 Earnings Release
2023-06-22 Society for Neuro-Oncology Biennial Pediatric Neuro-Oncology Research Conference
2023-06-22 12:00 pm Annual General Meeting
2023-06-14 02:20 pm Goldman Sachs Global Healthcare Conference
2023-06-05 02:15 pm American Society of Clinical Oncology Conference - Abstract Number: 10038
2023-06-05 02:15 pm American Society of Clinical Oncology Conference - Abstract Number: TPS10067
2023-06-04 07:00 pm American Society of Clinical Oncology Conference
2023-06-04 10:45 am American Society of Clinical Oncology Conference - Abstract Number: 10004
2023-05-09 American Society of Pediatric Oncology/Hematology Conference
2023-05-01 09:00 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

13,4

EBITDA
Million USD
Released
Forecast
Spread
0,00


-72,5
-71,0
-2.23%
-147
-147
-0.15%
-206
-201
-2.25%

-249

EBIT
Million USD
Released
Forecast
Spread
0,00


-72,7
-72,3
-0.55%
-147
-146
-0.83%
-206
-201
-2.66%

-242

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-72,8
-70,8
-2.73%
-142
-141
-0.58%
-189
-182
-4.08%

-227

Net income
Million USD
Released
Forecast
Spread
-40,5


-171
-136
-25.68%
-142
-143
0.54%
-189
-186
-1.58%

-227

EPS
USD
Released
Forecast
Spread
-17,0


-4,62
-3,77
-22.62%
-2,17
-2,18
0.52%
-2,37
-2,31
-2.45%

-2,62

Announcement Date04/05/2107/03/2206/03/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,76


4,12


8,69


19,7

EBITDA
Million USD
Released
Forecast
Spread
-21,9
-20,0
-9.62%
-27,7
-24,0
-15.59%
-36,7
-30,0
-22.38%
-39,7
-41,0
3.26%
-42,7
-41,4
-3.22%






-51,4
-50,0
-2.85%


















EBIT
Million USD
Released
Forecast
Spread
-22,0
-21,5
-2.11%
-27,7
-25,3
-9.53%
-36,7
-30,0
-22.4%
-39,7
-37,5
-5.81%
-42,7
-41,6
-2.87%
-45,9
-45,3
-1.22%
-49,3
-47,7
-3.16%
-51,4
-50,6
-1.73%
-59,5
-54,2
-9.84%

-59,5


-63,6


-60,1


-58,7


-48,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,9
-19,9
-10%
-27,7
-25,9
-7.13%
-36,5
-29,9
-22.04%
-37,8
-37,1
-1.77%
-40,1
-39,6
-1.23%
-42,4
-41,6
-1.82%
-45,9
-44,0
-4.25%
-46,2
-47,4
2.74%
-54,5
-49,0
-11.25%

-57,1


-59,5


-56,4


-54,1


-46,3

Net income
Million USD
Released
Forecast
Spread
-21,9
-19,9
-10%
-27,7
-25,9
-7.13%
-36,5
-29,9
-22.04%
-37,8
-37,4
-1.09%
-40,1
-40,6
1.3%
-42,4
-42,6
0.5%
-45,9
-45,3
-1.23%
-46,2
-48,3
4.46%
-54,5
-49,9
-9.18%

-57,0


-59,2


-57,4


-55,7


-46,3

EPS
USD
Released
Forecast
Spread
-0,35
-0,34
-5.1%
-0,48
-0,40
-18.93%
-0,60
-0,49
-22.85%
-0,53
-0,53
0.61%
-0,56
-0,57
1.32%
-0,59
-0,59
-0.49%
-0,61
-0,61
-0.76%
-0,54
-0,60
10.31%
-0,64
-0,58
-10.54%

-0,66


-0,67


-0,64


-0,62


-0,49

Announcement Date07/03/2212/05/2204/08/2207/11/2206/03/2301/05/2307/08/2306/11/2326/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DAWN Stock
  4. Calendar Day One Biopharmaceuticals, Inc.